David Dai's Stock Ratings

UBS Analyst

David Dai is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

-26.6%

Smart Score

28.8%

Overall Average Return Percentile

9th

Number of Ratings

23
Buy NowGet Alert
03/14/2025NUVLBuy Now
Nuvalent
$76.6630.45%
David Dai28%
$100 → $100UpgradeNeutral → BuyGet Alert
03/06/2025KURABuy Now
Kura Oncology
$7.3490.74%
David Dai28%
$27 → $14MaintainsBuyGet Alert
10/24/2024IMCRBuy Now
Immunocore Hldgs
$28.38-15.42%
David Dai28%
→ $24Initiates → SellGet Alert
10/24/2024NUVLBuy Now
Nuvalent
$76.6630.45%
David Dai28%
→ $100Initiates → NeutralGet Alert
10/24/2024BPMCBuy Now
Blueprint Medicines
$89.59-1.77%
David Dai28%
→ $88Initiates → NeutralGet Alert
10/24/2024CATXBuy Now
Perspective Therapeutics
$2.47709.72%
David Dai28%
→ $20Initiates → BuyGet Alert
10/24/2024NRIXBuy Now
Nurix Therapeutics
$13.66156.22%
David Dai28%
→ $35Initiates → BuyGet Alert
10/24/2024MRUSBuy Now
Merus
$46.3955.21%
David Dai28%
→ $72Initiates → BuyGet Alert
10/24/2024KURABuy Now
Kura Oncology
$7.34267.85%
David Dai28%
→ $27Initiates → BuyGet Alert
10/24/2024JANXBuy Now
Janux Therapeutics
$30.93123.08%
David Dai28%
→ $69Initiates → BuyGet Alert
10/24/2024IDYABuy Now
IDEAYA Biosciences
$18.47170.71%
David Dai28%
→ $50Initiates → BuyGet Alert
10/24/2024IOVABuy Now
Iovance Biotherapeutics
$3.58374.85%
David Dai28%
→ $17Initiates → BuyGet Alert
10/24/2024CGEMBuy Now
Cullinan Therapeutics
$8.93235.95%
David Dai28%
→ $30Initiates → BuyGet Alert
10/24/2024CGONBuy Now
CG Oncology
$27.48118.34%
David Dai28%
→ $60Initiates → BuyGet Alert
10/24/2024SNDXBuy Now
Syndax Pharmaceuticals
$12.61193.42%
David Dai28%
→ $37Initiates → BuyGet Alert
02/24/2023JNCEBuy Now
Jounce Therapeutics
——
David Dai28%
—DowngradeOutperform → NeutralGet Alert
03/31/2022ACETBuy Now
Adicet Bio
$0.783488.36%
David Dai28%
→ $28Initiates → OutperformGet Alert
03/16/2022INBXBuy Now
Inhibrx
$14.00185.71%
David Dai28%
→ $40Initiates → OutperformGet Alert
03/16/2022JNCEBuy Now
Jounce Therapeutics
——
David Dai28%
→ $17Initiates → OutperformGet Alert
02/04/2022MGNXBuy Now
Macrogenics
$2.211709.95%
David Dai28%
→ $40Initiates → OutperformGet Alert
11/18/2021NKTXBuy Now
Nkarta
$1.533167.97%
David Dai28%
→ $50Initiates → OutperformGet Alert
03/17/2020JDBuy Now
JD.com
$45.0315.48%
David Dai28%
$41 → $52UpgradeMarket Perform → OutperformGet Alert
04/25/2017SNEBuy Now
Sony
——
David Dai28%
→ $41Initiates → OutperformGet Alert